NIRAMAI Health Analytix
Bangalore
About NIRAMAI Health Analytix
Breast Cancer is the leading type of cancer in women. According to WHO, one in every 8 women in US is at the risk of developing a breast abnormality in her life time. It is well-established that early diagnosis is very critical in saving a life of a cancer patient. They at NIRAMAI have developed a new cancer screening software that uses machine intelligence over thermography images to enable a low cost, easy to use, portable solution and requires minimal human supervision. Their solution can detect cancer at a much earlier stage than traditional diagnostic methods and self-examination and can therefore improve survival rates. Their method of breast cancer screening can detect tumors 5 times smaller than what clinical exam can detect, is non-contact, painless and free of any radiation, apart from being low-cost, and universally accessible. With their solution, women of all age groups can undergo frequent screening without any side-effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (May 2024)
- Website: niramai.com
- Phone: +91 8660922978
Industries & Categories
Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/niramai-health-analytix-5093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.